Your Rights as an AGEN Shareholder
If you're a shareholder of Agenus Inc. (NASDAQ: AGEN), it's crucial to understand your rights, especially if you bought shares during the specified class period. Your participation could help you secure your interests in this evolving situation.
Understanding the Class Period
The class period for this case extends from January 23, 2023, to July 17, 2024. If you purchased shares within this time frame, you may want to act swiftly to explore your options. Taking part in such actions may not require you to act as a lead plaintiff, but the opportunity exists for those who wish to step up.
Why You Should Register
Registration for the class action allows shareholders to receive updates and insights regarding the case, ensuring you stay informed every step of the way. The deadline for registration is approaching, so it's best not to delay. By registering, you will also gain access to monitoring software that provides real-time updates on your investment's status.
Allegations Against the Company
The allegations suggest that the company failed to fully disclose significant information regarding the effectiveness of its combination therapy involving botensilimab and balstilimab. These claims assert that the clinical results and prospects were excessively optimistic, which potentially misled investors about the true state of the company's performance.
Next Steps for AGEN Shareholders
If you are a shareholder and have not registered yet, it is imperative to do so before the November deadline of 2024. Failure to register may result in missing out on potential recovery opportunities if allegations hold true. It's critical to take action as soon as possible and seek additional guidance from legal experts if needed.
Why Choose the Gross Law Firm?
The Gross Law Firm specializes in protecting investors’ rights. Their commitment to holding companies accountable for misleading practices means that they work diligently to recover losses incurred by shareholders. Their reputation for success and dedication can provide peace of mind to investors engaging in this legal process.
The Importance of Corporate Responsibility
Corporate accountability is vital in maintaining investor trust. The Gross Law Firm emphasizes the necessity for companies to engage in responsible business practices. Engaging in open disclosures not only benefits investors but also strengthens the overall market. Through this legal action, investors can seek rectification for any wrongs experienced as a result of corporate decisions.
Frequently Asked Questions
What is the class action period for AGEN shareholders?
The class action period extends from January 23, 2023, to July 17, 2024, for shareholders who purchased AGEN shares during this timeframe.
What should I do if I bought shares of AGEN?
If you purchased shares of AGEN during the class action period, it is essential to register for the class action to ensure your rights are protected and to receive important updates.
What allegations are being made against Agenus Inc.?
The lawsuits assert that Agenus disclosed misleading information regarding the effectiveness and prospects of its immuno-oncology products, deceiving investors about the company’s true performance.
How can I contact the Gross Law Firm?
You can reach the Gross Law Firm directly through their phone number or email. They are located at 15 West 38th Street, 12th floor, New York, NY 10018.
Is there a cost to participate in the class action?
No, there is no cost or obligation to participate in the class action for shareholders, allowing you to explore your options at no financial risk.
